Primary Site >> Biliary tract Cancer
Gene >> CDH17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. PMID: 9537436 |
Ref: Beta-catenin mutations in biliary tract cancers: a population-based study in China. PMID: 11309300 Ref: Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. PMID: 11557787 |
Ref: The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin. PMID: 11906618 Ref: Establishment and characterisation of six human biliary tract cancer cell lines. PMID: 12107841 |
Ref: Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers. PMID: 15915369 Ref: E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue. PMID: 16309224 Ref: FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma. PMID: 16311342 |
Ref: Expression of E-cadherin and beta-catenin in the adenoma-carcinoma sequence of ampulla of Vater cancer. PMID: 16506371 Ref: Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. PMID: 16818635 Ref: Intrahepatic sarcomatoid cholangiocarcinoma of round cell variant: a case report and immunohistochemical studies. PMID: 17033799 |
Ref: Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. PMID: 17919228 |
Ref: Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma. PMID: 18691339 |
Ref: Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. PMID: 19116147 Ref: Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. PMID: 20309424 |
Ref: Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition. PMID: 19956832 Ref: Loss of liver-intestine cadherin in human intrahepatic cholangiocarcinoma promotes angiogenesis by up-regulating metal-responsive transcription factor-1 and placental growth factor. PMID: 19956853 Ref: Loss of E-cadherin and beta-catenin is correlated with poor prognosis of ampullary neoplasms. PMID: 20119975 Ref: Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion. PMID: 20135719 Ref: Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma. PMID: 20489148 Ref: CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells. PMID: 21189991 |
Ref: Liver-intestine cadherin in intraepithelial neoplasia of intrahepatic cholangiocarcinoma. PMID: 22024075 Ref: E/N-cadherin switch mediates cancer progression via TGF-beta-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. PMID: 22068819 |
Ref: Establishment and characterization of a cell line, EH-GB2, derived from hepatic metastasis of gallbladder cancer. PMID: 22134783 Ref: Clinicopathological significance of E-cadherin, beta-catenin and epidermal growth factor receptor expression in intrahepatic cholangiocarcinoma. PMID: 22281980 Ref: Significance of epithelial growth factor in the epithelial-mesenchymal transition of human gallbladder cancer cells. PMID: 22404757 Ref: Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist. PMID: 22540680 Ref: Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma. PMID: 22664794 Ref: Tumor necrosis factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. PMID: 22903530 |
Ref: Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma. PMID: 24062361 Ref: Decorin-mediated inhibition of cholangiocarcinoma cell growth and migration and promotion of apoptosis are associated with E-cadherin in vitro. PMID: 24272200 Ref: Differential expression of E-cadherin, beta-catenin, and S100A4 in intestinal type and nonintestinal type ampulla of Vater cancers. PMID: 24516707 Ref: EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. PMID: 24704591 Ref: Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients. PMID: 24816558 Ref: Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. PMID: 24867095 Ref: BMP-7 blocks the effects of TGF-beta-induced EMT in cholangiocarcinoma. PMID: 24969562 Ref: Forkhead box L1 is frequently downregulated in gallbladder cancer and inhibits cell growth through apoptosis induction by mitochondrial dysfunction. PMID: 25010679 Ref: Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray. PMID: 25077440 Ref: Signet ring cell carcinoma of the ampulla of Vater: Immunophenotype and differentiation. PMID: 25202392 |
Ref: Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis. PMID: 25744243 Ref: Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. PMID: 25854403 Ref: Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of beta-Catenin in Mice. PMID: 26033745 Ref: Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition. PMID: 26043778 Ref: Proteomics profiling of cholangiocarcinoma exosomes: A potential role of oncogenic protein transferring in cancer progression. PMID: 26148937 |
Ref: Fascin Overexpression Promotes Cholangiocarcinoma RBE Cell Proliferation, Migration, and Invasion. PMID: 25882880 Ref: WAVE3 Induces EMT and Promotes Migration and Invasion in Intrahepatic Cholangiocarcinoma. PMID: 26971088 Ref: Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition. PMID: 27073719 |
Ref: Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro. PMID: 28096273 Ref: TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. PMID: 28423362 Ref: Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands. PMID: 28439013 Ref: Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- beta1-SMAD3-ID1 signaling pathway. PMID: 28611292 Ref: Blocking ERK1/2 signaling impairs TGF-beta1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells. PMID: 28959141 |
Ref: CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma. PMID: 29510695 Ref: S100A11 promotes TGF-beta1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma. PMID: 29569474 Ref: [Kindlin-2 promotes gallbladder cancer metastasis and invasion by inducing epithelial-mesenchymal transition]. PMID: 30107706 |